Drugs & Targets GenomeDx, Astellas work to identify genomic drivers of Xtandi response February 10, 2017Vol.43 No.06
Drugs & Targets MD Anderson, Guardant form partnership to make liquid biopsy standard of care February 03, 2017Vol.43 No.05
Drugs & Targets Addario institute and Scancell form partnership focused on vaccine February 03, 2017Vol.43 No.05
Drugs & Targets Perthera enters collaboration with Novartis to identify patients for clinical trials February 03, 2017Vol.43 No.05
Drugs & Targets Benitec, Nant Capital initiate head and neck cancer programs February 03, 2017Vol.43 No.05
Drugs & Targets GenomeDx joins Astellas in genomic profiling collaboration February 03, 2017Vol.43 No.05
Drugs & Targets Merck, Domain Therapeutics collaborate in immune-oncology January 27, 2017Vol.43 No.04
Drugs & Targets Tecentriq receives priority review for treatment of urothelial carcinoma January 25, 2017Vol.40 No.01
